CFRHF(CFRHF)
CFRHF
No analyst ratings available
No analyst price targets available for CFRHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $24.78B | $26.67B | $28.60B | $29.88B |
| Low | $23.86B | $25.20B | $27.27B | $28.49B |
| High | $25.37B | $27.83B | $29.57B | $30.89B |
| EBITDA Avg | $7.30B | $7.85B | $8.42B | $8.80B |
| Low | $7.03B | $7.42B | $8.03B | $8.39B |
| High | $7.47B | $8.20B | $8.71B | $9.10B |
| EBIT Avg | $5.59B | $6.01B | $6.45B | $6.74B |
| Low | $5.38B | $5.68B | $6.15B | $6.42B |
| High | $5.72B | $6.27B | $6.67B | $6.97B |
| Net Income Avg | $4.33B | $4.97B | $5.56B | $5.55B |
| Low | $4.07B | $4.67B | $5.23B | $5.22B |
| High | $4.52B | $5.19B | $5.81B | $5.80B |
| EPS Avg | $7.35 | $8.44 | $9.43 | $9.42 |
| Low | $6.90 | $7.93 | $8.86 | $8.85 |
| High | $7.67 | $8.81 | $9.85 | $9.83 |
| Analysts (Rev / EPS) | 23 / 6 | 25 / 7 | 12 / 10 | 12 / 6 |
| Metric | Q3 2026 | Q1 2027 |
|---|---|---|
| Revenue Avg | $5.14B | $6.10B |
| Low | $4.96B | $6.00B |
| High | $5.37B | $6.23B |
| EBITDA Avg | $1.51B | $1.80B |
| Low | $1.46B | $1.77B |
| High | $1.58B | $1.83B |
| EBIT Avg | $1.16B | $1.38B |
| Low | $1.12B | $1.35B |
| High | $1.21B | $1.40B |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 4 / — | 4 / — |